Clinical trial · Observational
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
Healthy Bones, Healthy Life: Effect of Habitual Physical Activity on Bone and Metabolic Health in Pediatric Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project will examine habitual physical activity, bone health, and insulin resistance in pediatric acute lymphocytic leukemia (ALL) and lymphoma cancer survivors at two time points: baseline and 6 months. At the two study timepoints, all study participants will be asked to wear an accelerometer, receive a DXA scan of the lumbar spine and hip, and have blood drawn for analysis. Study participants will be given a gift card stipend for each study visit attended. Study visits will coincide with regular office visits to Children's Hospital Oncology Clinic and the Children's Hospital Survivorship Clinics whenever possible. The potential mechanism by which physical activity mediates bone changes will be explored by concurrently measuring changes in lean/fat mass and metabolic status. This pilot study will provide data to inform the design of a randomized controlled trial to test the effect of a physical activity intervention on bone health in PCS.
Conditions
Conditions (13)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia, Pediatric | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
| Bone Loss | — | UNRESOLVED | — |
| Habitual Physical Activity | — | UNRESOLVED | — |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Lymphoid Leukemia | Lymphoid Leukemia | ONTOLOGY_EXACT | 0.98 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Metabolic Syndrome | — | UNRESOLVED | — |
| Osteoporosis | — | UNRESOLVED | — |
| Osteoporosis Risk |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Pediatric Cancer Survivors
- description
- Children and adolescents who have completed treatment of for acute lymphoblastic leukemia (ALL) and lymphoma.
Primary outcomes (3)
- measure
- Bone Mineral Density (g/cm2)
- timeFrame
- 6 months
- description
- z-score of lumbar Spine bone density- DXA scan
- measure
- Hip structural analysis
- timeFrame
- 6 months
- description
- DXA scan
- measure
- Physical Activity Level
- timeFrame
- 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Children between the ages of 5-18 2. Diagnosis of ALL or Lymphoma 3. Between 1-13 months post-cancer treatment Exclusion Criteria: 1. Children younger than 5 years old or 19 or older 2. Children without a diagnosis of ALL or lymphoma 3. Children receiving ongoing cancer treatment 4. Children with Down syndrome (identified as a precancerous condition affecting BMD) 5. Children with a prior history of bisphosphonate use or other medication directed at increasing bone density
References
Publications (0)
Data not yet available